Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Actavis Iceland president honoured with Order of the Falcon

This article was originally published in Scrip

Executive Summary

Following the announcement of Andrew Witty's knighthood (scripintelligence.com, 4 January 2012), pharma leaders continue to gain national recognition as Gudbjorg Eggertsdottir, president of Actavis Iceland, has been awarded the Order of the Falcon in Iceland's New Year's Honours. Ms Eggertsdottir was presented the order by president of Iceland, Olafur Grimsson, in recognition of her "remarkable contribution to healthcare and the national economy". She has been active in the generics field for over 30 years, and represents the generics industry in Europe through her role as president of the European Generic medicines Association. The Order of the Falcon is the highest honour the Icelandic state can bestow.

You may also be interested in...



Almirall launches Constella in six European markets

Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.

Dermira raises $35m in series B

Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.

Clovis ups public offering to $240m

Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

SC015840

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel